Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Liver Diseases

  Free Subscription


Articles published in Eur Radiol

Retrieve available abstracts of 202 articles:
HTML format
Text format



Single Articles


    November 2019
  1. CHOI SL, Lee ES, Ko A, Park HJ, et al
    Technical success rates and reliability of spin-echo echo-planar imaging (SE-EPI) MR elastography in patients with chronic liver disease or liver cirrhosis.
    Eur Radiol. 2019 Nov 14. pii: 10.1007/s00330-019-06496.
    PubMed     Text format     Abstract available


  2. REITER R, Tzschatzsch H, Schwahofer F, Haas M, et al
    Diagnostic performance of tomoelastography of the liver and spleen for staging hepatic fibrosis.
    Eur Radiol. 2019 Nov 11. pii: 10.1007/s00330-019-06471.
    PubMed     Text format     Abstract available


    October 2019
  3. SEMAAN S, Vietti Violi N, Lewis S, Chatterji M, et al
    Hepatocellular carcinoma detection in liver cirrhosis: diagnostic performance of contrast-enhanced CT vs. MRI with extracellular contrast vs. gadoxetic acid.
    Eur Radiol. 2019 Oct 31. pii: 10.1007/s00330-019-06458.
    PubMed     Text format     Abstract available


  4. GUO H, Liao M, Jin J, Zeng J, et al
    How intrahepatic cholestasis affects liver stiffness in patients with chronic hepatitis B: a study of 1197 patients with liver biopsy.
    Eur Radiol. 2019 Oct 30. pii: 10.1007/s00330-019-06451.
    PubMed     Text format     Abstract available


  5. FRAUM TJ, Cannella R, Ludwig DR, Tsai R, et al
    Assessment of primary liver carcinomas other than hepatocellular carcinoma (HCC) with LI-RADS v2018: comparison of the LI-RADS target population to patients without LI-RADS-defined HCC risk factors.
    Eur Radiol. 2019 Oct 25. pii: 10.1007/s00330-019-06448.
    PubMed     Text format     Abstract available


    September 2019
  6. ZIMMERMANN M, Pedersoli F, Schulze-Hagen M, Lurje G, et al
    Salvage RFA in patients with intrahepatic recurrence after major hepatic surgery for colorectal cancer liver metastases: mid-term outcome.
    Eur Radiol. 2019 Sep 6. pii: 10.1007/s00330-019-06421.
    PubMed     Text format     Abstract available


  7. SCHULLIAN P, Putzer D, Laimer G, Levy E, et al
    Feasibility, safety, and long-term efficacy of stereotactic radiofrequency ablation for tumors adjacent to the diaphragm in the hepatic dome: a case-control study.
    Eur Radiol. 2019 Sep 5. pii: 10.1007/s00330-019-06399.
    PubMed     Text format     Abstract available


    August 2019
  8. MOCHE M, Busse H, Futterer JJ, Hinestrosa CA, et al
    Clinical evaluation of in silico planning and real-time simulation of hepatic radiofrequency ablation (ClinicIMPPACT Trial).
    Eur Radiol. 2019 Aug 30. pii: 10.1007/s00330-019-06411.
    PubMed     Text format     Abstract available


  9. MOKRANE FZ, Lu L, Vavasseur A, Otal P, et al
    Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules.
    Eur Radiol. 2019 Aug 23. pii: 10.1007/s00330-019-06347.
    PubMed     Text format     Abstract available


  10. SEO N, Kim MS, Park MS, Choi JY, et al
    Evaluation of treatment response in hepatocellular carcinoma in the explanted liver with Liver Imaging Reporting and Data System version 2017.
    Eur Radiol. 2019 Aug 15. pii: 10.1007/s00330-019-06376.
    PubMed     Text format     Abstract available


  11. CHOURAQUI E, Leguilloux L, Dohan A, Gouya H, et al
    Can we differentiate HIV-associated obliterative portopathy from liver cirrhosis using MRI?
    Eur Radiol. 2019 Aug 13. pii: 10.1007/s00330-019-06391.
    PubMed     Text format     Abstract available


  12. HENNINGER B, Alustiza J, Garbowski M, Gandon Y, et al
    Practical guide to quantification of hepatic iron with MRI.
    Eur Radiol. 2019 Aug 7. pii: 10.1007/s00330-019-06380.
    PubMed     Text format     Abstract available


  13. RIMOLA J, Forner A, Sapena V, Llarch N, et al
    Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma.
    Eur Radiol. 2019 Aug 1. pii: 10.1007/s00330-019-06351.
    PubMed     Text format     Abstract available


  14. KROKIDIS M, Hungerbuhler M, Hewer E, Heverhagen J, et al
    Ex vivo performance comparison of three percutaneous biopsy needle systems.
    Eur Radiol. 2019;29:4044-4049.
    PubMed     Text format     Abstract available


  15. CHEN LD, Ruan SM, Lin Y, Liang JY, et al
    Comparison between M-score and LR-M in the reporting system of contrast-enhanced ultrasound LI-RADS.
    Eur Radiol. 2019;29:4249-4257.
    PubMed     Text format     Abstract available


  16. RUITER SJS, Heerink WJ, de Jong KP
    Liver microwave ablation: a systematic review of various FDA-approved systems.
    Eur Radiol. 2019;29:4026-4035.
    PubMed     Text format     Abstract available


  17. AHN SJ, Kim JH, Lee SM, Park SJ, et al
    CT reconstruction algorithms affect histogram and texture analysis: evidence for liver parenchyma, focal solid liver lesions, and renal cysts.
    Eur Radiol. 2019;29:4008-4015.
    PubMed     Text format     Abstract available


  18. KOULAKIAN H, Allaham W, Vilgrain V, Ronot M, et al
    Non-measurable infiltrative HCC: is post-contrast attenuation on CT a sign of tumor response?
    Eur Radiol. 2019;29:4389-4399.
    PubMed     Text format     Abstract available


    July 2019
  19. DIOGUARDI BURGIO M, Benseghir T, Roche V, Garcia Alba C, et al
    Clinical impact of a new cone beam CT angiography respiratory motion artifact reduction algorithm during hepatic intra-arterial interventions.
    Eur Radiol. 2019 Jul 29. pii: 10.1007/s00330-019-06355.
    PubMed     Text format     Abstract available


  20. PENG J, Kang S, Ning Z, Deng H, et al
    Residual convolutional neural network for predicting response of transarterial chemoembolization in hepatocellular carcinoma from CT imaging.
    Eur Radiol. 2019 Jul 22. pii: 10.1007/s00330-019-06318.
    PubMed     Text format     Abstract available


  21. LI F, Li Q, Liu Y, Han J, et al
    Distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma in patients with and without risks: the evaluation of the LR-M criteria of contrast-enhanced ultrasound liver imaging reporting and data system version 2017.
    Eur Radiol. 2019 Jul 11. pii: 10.1007/s00330-019-06317.
    PubMed     Text format     Abstract available


  22. WENG Z, Zhou L, Wu Q, Zhou W, et al
    Enlarged hepatic hilar lymph node: an additional ultrasonographic feature that may be helpful in the diagnosis of biliary atresia.
    Eur Radiol. 2019 Jul 11. pii: 10.1007/s00330-019-06339.
    PubMed     Text format     Abstract available


  23. KOZAKA K, Kobayashi S, Yoneda N, Kitao A, et al
    Doughnut-like hyperintense nodules on hepatobiliary phase without arterial-phase hyperenhancement in cirrhotic liver: imaging and clinicopathological features.
    Eur Radiol. 2019 Jul 5. pii: 10.1007/s00330-019-06329.
    PubMed     Text format     Abstract available


  24. WANG CJ, Hamm CA, Savic LJ, Ferrante M, et al
    Deep learning for liver tumor diagnosis part II: convolutional neural network interpretation using radiologic imaging features.
    Eur Radiol. 2019;29:3348-3357.
    PubMed     Text format     Abstract available


  25. HAMM CA, Wang CJ, Savic LJ, Ferrante M, et al
    Deep learning for liver tumor diagnosis part I: development of a convolutional neural network classifier for multi-phasic MRI.
    Eur Radiol. 2019;29:3338-3347.
    PubMed     Text format     Abstract available


  26. KIM JE, Kim HO, Bae K, Choi DS, et al
    T1 mapping for liver function evaluation in gadoxetic acid-enhanced MR imaging: comparison of look-locker inversion recovery and B1 inhomogeneity-corrected variable flip angle method.
    Eur Radiol. 2019;29:3584-3594.
    PubMed     Text format     Abstract available


  27. HONG SB, Choi SH, Kim KW, Park SH, et al
    Diagnostic performance of [(18)F]FDG-PET/MRI for liver metastasis in patients with primary malignancy: a systematic review and meta-analysis.
    Eur Radiol. 2019;29:3553-3563.
    PubMed     Text format     Abstract available


  28. JANG JK, Kim KW, Choi SH, Jeong SY, et al
    CT of acute rejection after liver transplantation: a matched case-control study.
    Eur Radiol. 2019;29:3736-3745.
    PubMed     Text format     Abstract available


  29. CHEUNG HMC, Kim JK, Hudson J, Coburn N, et al
    Late gadolinium MRI enhancement of colorectal liver metastases is associated with overall survival among nonsurgical patients.
    Eur Radiol. 2019;29:3901-3907.
    PubMed     Text format     Abstract available


    June 2019
  30. LI J, Wang J, Lei L, Yuan G, et al
    The diagnostic performance of gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced multi-detector computed tomography in detecting hepatocellular carcinoma: a meta-analysis of eight prospective studies.
    Eur Radiol. 2019 Jun 27. pii: 10.1007/s00330-019-06294.
    PubMed     Text format     Abstract available


  31. LANGENBACH MC, Vogl TJ, von den Driesch I, Kaltenbach B, et al
    Analysis of Lipiodol uptake in angiography and computed tomography for the diagnosis of malignant versus benign hepatocellular nodules in cirrhotic liver.
    Eur Radiol. 2019 Jun 24. pii: 10.1007/s00330-019-06297.
    PubMed     Text format     Abstract available


  32. BELLER E, Lorbeer R, Keeser D, Schoeppe F, et al
    Hepatic fat is superior to BMI, visceral and pancreatic fat as a potential risk biomarker for neurodegenerative disease.
    Eur Radiol. 2019 Jun 11. pii: 10.1007/s00330-019-06276.
    PubMed     Text format     Abstract available


  33. BAE JS, Lee DH, Lee JY, Kim H, et al
    Assessment of hepatic steatosis by using attenuation imaging: a quantitative, easy-to-perform ultrasound technique.
    Eur Radiol. 2019 Jun 7. pii: 10.1007/s00330-019-06272.
    PubMed     Text format     Abstract available


  34. LV P, Zhou Z, Liu J, Chai Y, et al
    Can virtual monochromatic images from dual-energy CT replace low-kVp images for abdominal contrast-enhanced CT in small- and medium-sized patients?
    Eur Radiol. 2019;29:2878-2889.
    PubMed     Text format     Abstract available


    May 2019
  35. KANG YK, Choi JY, Paeng JC, Kim YI, et al
    Composite criteria using clinical and FDG PET/CT factors for predicting recurrence of hepatocellular carcinoma after living donor liver transplantation.
    Eur Radiol. 2019 May 21. pii: 10.1007/s00330-019-06239.
    PubMed     Text format     Abstract available


  36. LUO Y, Ameli S, Pandey A, Khoshpouri P, et al
    Semi-quantitative visual assessment of hepatic tumor burden can reliably predict survival in neuroendocrine liver metastases treated with transarterial chemoembolization.
    Eur Radiol. 2019 May 9. pii: 10.1007/s00330-019-06246.
    PubMed     Text format     Abstract available


  37. LANGENBACH MC
    RFA vs resection of HCC: exploring the past to improve the future.
    Eur Radiol. 2019;29:2677-2678.
    PubMed     Text format    


  38. KIM DW, Park C, Yoon HM, Jung AY, et al
    Technical performance of shear wave elastography for measuring liver stiffness in pediatric and adolescent patients: a systematic review and meta-analysis.
    Eur Radiol. 2019;29:2560-2572.
    PubMed     Text format     Abstract available


  39. KAYE EA, Cornelis FH, Petre EN, Tyagi N, et al
    Volumetric 3D assessment of ablation zones after thermal ablation of colorectal liver metastases to improve prediction of local tumor progression.
    Eur Radiol. 2019;29:2698-2705.
    PubMed     Text format     Abstract available


  40. GRGUREVIC I, Salkic N, Bozin T, Mustapic S, et al
    Magnitude dependent discordance in liver stiffness measurements using elastography point quantification with transient elastography as the reference test.
    Eur Radiol. 2019;29:2448-2456.
    PubMed     Text format     Abstract available


    April 2019
  41. ABE H, Midorikawa Y, Matsumoto N, Moriyama M, et al
    Prediction of esophageal varices by liver and spleen MR elastography.
    Eur Radiol. 2019 Apr 30. pii: 10.1007/s00330-019-06230.
    PubMed     Text format     Abstract available


  42. MATOORI S, Froehlich JM, Breitenstein S, Pozdniakova V, et al
    Serum albumin, total bilirubin, and patient age are independent confounders of hepatobiliary-phase gadoxetate parenchymal liver enhancement.
    Eur Radiol. 2019 Apr 24. pii: 10.1007/s00330-019-06179.
    PubMed     Text format     Abstract available


  43. LEBERT P, Adens-Fauquembergue M, Azahaf M, Gnemmi V, et al
    MRI for characterization of benign hepatocellular tumors on hepatobiliary phase: the added value of in-phase imaging and lesion-to-liver visual signal intensity ratio.
    Eur Radiol. 2019 Apr 16. pii: 10.1007/s00330-019-06210.
    PubMed     Text format     Abstract available


  44. HONG SB, Lee NK, Kim S, Seo HI, et al
    Modified CAIPIRINHA-VIBE without view-sharing on gadoxetic acid-enhanced multi-arterial phase MR imaging for diagnosing hepatocellular carcinoma: comparison with the CAIPIRINHA-Dixon-TWIST-VIBE.
    Eur Radiol. 2019 Apr 16. pii: 10.1007/s00330-019-06095.
    PubMed     Text format     Abstract available


  45. REIZINE E, Ronot M, Pigneur F, Purcell Y, et al
    Iso- or hyperintensity of hepatocellular adenomas on hepatobiliary phase does not always correspond to hepatospecific contrast-agent uptake: importance for tumor subtyping.
    Eur Radiol. 2019 Apr 1. pii: 10.1007/s00330-019-06150.
    PubMed     Text format     Abstract available


  46. KIM YC, Min JH, Kim YK, Lee SJ, et al
    Intra-individual comparison of gadolinium-enhanced MRI using pseudo-golden-angle radial acquisition with gadoxetic acid-enhanced MRI for diagnosis of HCCs using LI-RADS.
    Eur Radiol. 2019;29:2058-2068.
    PubMed     Text format     Abstract available


  47. GROSSE HOKAMP N, Abdullayev N, Persigehl T, Schlaak M, et al
    Precision and reliability of liver iodine quantification from spectral detector CT: evidence from phantom and patient data.
    Eur Radiol. 2019;29:2098-2106.
    PubMed     Text format     Abstract available


    March 2019
  48. YOSHIMITSU K
    Differentiation of two subtypes of intrahepatic cholangiocarcinoma: imaging approach.
    Eur Radiol. 2019 Mar 26. pii: 10.1007/s00330-019-06135.
    PubMed     Text format     Abstract available


  49. JI GW, Zhu FP, Zhang YD, Liu XS, et al
    A radiomics approach to predict lymph node metastasis and clinical outcome of intrahepatic cholangiocarcinoma.
    Eur Radiol. 2019 Mar 26. pii: 10.1007/s00330-019-06142.
    PubMed     Text format     Abstract available


  50. GU J, Liu S, Du S, Zhang Q, et al
    Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis.
    Eur Radiol. 2019 Mar 21. pii: 10.1007/s00330-019-06072.
    PubMed     Text format     Abstract available


  51. FALLER TL, Trotier AJ, Miraux S, Ribot EJ, et al
    Radial MP2RAGE sequence for rapid 3D T1 mapping of mouse abdomen: application to hepatic metastases.
    Eur Radiol. 2019 Mar 19. pii: 10.1007/s00330-019-06081.
    PubMed     Text format     Abstract available


  52. BIKO DM, Smith CL, Otero HJ, Saul D, et al
    Intrahepatic dynamic contrast MR lymphangiography: initial experience with a new technique for the assessment of liver lymphatics.
    Eur Radiol. 2019 Mar 18. pii: 10.1007/s00330-019-06112.
    PubMed     Text format     Abstract available


  53. YIN Z, Murphy MC, Li J, Glaser KJ, et al
    Prediction of nonalcoholic fatty liver disease (NAFLD) activity score (NAS) with multiparametric hepatic magnetic resonance imaging and elastography.
    Eur Radiol. 2019 Mar 18. pii: 10.1007/s00330-019-06076.
    PubMed     Text format     Abstract available


  54. QU Y, Li M, Hamilton G, Zhang YN, et al
    Diagnostic accuracy of hepatic proton density fat fraction measured by magnetic resonance imaging for the evaluation of liver steatosis with histology as reference standard: a meta-analysis.
    Eur Radiol. 2019 Mar 15. pii: 10.1007/s00330-019-06071.
    PubMed     Text format     Abstract available


  55. SEO N, Kim MJ, Rhee H
    Hepatic sarcomatoid carcinoma: magnetic resonance imaging evaluation by using the liver imaging reporting and data system.
    Eur Radiol. 2019 Mar 11. pii: 10.1007/s00330-019-06052.
    PubMed     Text format     Abstract available


  56. ZHENG W, Zhou ZG, Wong CH, Pei XQ, et al
    Evaluation of liver parenchyma stiffness in patients with liver tumours: optimal strategy for shear wave elastography.
    Eur Radiol. 2019;29:1479-1488.
    PubMed     Text format     Abstract available


  57. JOSKOWICZ L, Cohen D, Caplan N, Sosna J, et al
    Inter-observer variability of manual contour delineation of structures in CT.
    Eur Radiol. 2019;29:1391-1399.
    PubMed     Text format     Abstract available


  58. IEZZI R, Pompili M, Rinninella E, Annicchiarico E, et al
    TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib.
    Eur Radiol. 2019;29:1285-1292.
    PubMed     Text format     Abstract available


  59. KIM YY, Choi JY, Sirlin CB, An C, et al
    Pitfalls and problems to be solved in the diagnostic CT/MRI Liver Imaging Reporting and Data System (LI-RADS).
    Eur Radiol. 2019;29:1124-1132.
    PubMed     Text format     Abstract available


    February 2019
  60. RASSAM F, Zhang T, Cieslak KP, Lavini C, et al
    Comparison between dynamic gadoxetate-enhanced MRI and (99m)Tc-mebrofenin hepatobiliary scintigraphy with SPECT for quantitative assessment of liver function.
    Eur Radiol. 2019 Feb 22. pii: 10.1007/s00330-019-06029.
    PubMed     Text format     Abstract available


  61. KIM MJ, Lee S, An C
    Problematic lesions in cirrhotic liver mimicking hepatocellular carcinoma.
    Eur Radiol. 2019 Feb 20. pii: 10.1007/s00330-019-06030.
    PubMed     Text format     Abstract available


  62. MA X, Wei J, Gu D, Zhu Y, et al
    Preoperative radiomics nomogram for microvascular invasion prediction in hepatocellular carcinoma using contrast-enhanced CT.
    Eur Radiol. 2019 Feb 15. pii: 10.1007/s00330-018-5985.
    PubMed     Text format     Abstract available


  63. LEE DH, Lee JM, Kim PN, Jang YJ, et al
    Whole tumor ablation of locally recurred hepatocellular carcinoma including retained iodized oil after transarterial chemoembolization improves progression-free survival.
    Eur Radiol. 2019 Feb 15. pii: 10.1007/s00330-018-5993.
    PubMed     Text format     Abstract available


  64. CARLING U, Barkhatov L, Reims HM, Storas T, et al
    Can we ablate liver lesions close to large portal and hepatic veins with MR-guided HIFU? An experimental study in a porcine model.
    Eur Radiol. 2019 Feb 8. pii: 10.1007/s00330-018-5996.
    PubMed     Text format     Abstract available


  65. POETTER-LANG S, Staufer K, Baltzer P, Tamandl D, et al
    The Efficacy of MRI in the diagnostic workup of cystic fibrosis-associated liver disease: A clinical observational cohort study.
    Eur Radiol. 2019;29:1048-1058.
    PubMed     Text format     Abstract available


  66. JHAVERI KS, Hosseini-Nik H, Sadoughi N, Janssen H, et al
    The development and validation of magnetic resonance elastography for fibrosis staging in primary sclerosing cholangitis.
    Eur Radiol. 2019;29:1039-1047.
    PubMed     Text format     Abstract available


  67. LEE S, Kim SH, Hwang JA, Lee JE, et al
    Pre-operative ADC predicts early recurrence of HCC after curative resection.
    Eur Radiol. 2019;29:1003-1012.
    PubMed     Text format     Abstract available


  68. CHEUNG HMC, Karanicolas PJ, Coburn N, Seth V, et al
    Delayed tumour enhancement on gadoxetate-enhanced MRI is associated with overall survival in patients with colorectal liver metastases.
    Eur Radiol. 2019;29:1032-1038.
    PubMed     Text format     Abstract available


    January 2019
  69. FENG ST, Jia Y, Liao B, Huang B, et al
    Preoperative prediction of microvascular invasion in hepatocellular cancer: a radiomics model using Gd-EOB-DTPA-enhanced MRI.
    Eur Radiol. 2019 Jan 28. pii: 10.1007/s00330-018-5935.
    PubMed     Text format     Abstract available


  70. CHEN S, Feng S, Wei J, Liu F, et al
    Pretreatment prediction of immunoscore in hepatocellular cancer: a radiomics-based clinical model based on Gd-EOB-DTPA-enhanced MRI imaging.
    Eur Radiol. 2019 Jan 21. pii: 10.1007/s00330-018-5986.
    PubMed     Text format     Abstract available


  71. BONATTI M, Valletta R, Zamboni GA, Lombardo F, et al
    Ascites relative enhancement during hepatobiliary phase after Gd-BOPTA administration: a new promising tool for characterising abdominal free fluid of unknown origin.
    Eur Radiol. 2019 Jan 14. pii: 10.1007/s00330-018-5932.
    PubMed     Text format     Abstract available


  72. LEE DH, Lee JM, Yu MH, Hur BY, et al
    Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MR can help determine the treatment method for HCC.
    Eur Radiol. 2019 Jan 14. pii: 10.1007/s00330-018-5941.
    PubMed     Text format     Abstract available


  73. KIM SS, Hwang JA, Shin HC, Choi SY, et al
    LI-RADS v2017 categorisation of HCC using CT: Does moderate to severe fatty liver affect accuracy?
    Eur Radiol. 2019;29:186-194.
    PubMed     Text format     Abstract available


  74. TRUHN D, Kuhl CK, Ciritsis A, Barabasch A, et al
    A New Model for MR Evaluation of Liver Function with Gadoxetic Acid, Including Both Uptake and Excretion.
    Eur Radiol. 2019;29:383-391.
    PubMed     Text format     Abstract available


  75. CREASY JM, Midya A, Chakraborty J, Adams LB, et al
    Quantitative imaging features of pretreatment CT predict volumetric response to chemotherapy in patients with colorectal liver metastases.
    Eur Radiol. 2019;29:458-467.
    PubMed     Text format     Abstract available


    December 2018
  76. BYUN J, Lee SS, Sung YS, Shin Y, et al
    CT indices for the diagnosis of hepatic steatosis using non-enhanced CT images: development and validation of diagnostic cut-off values in a large cohort with pathological reference standard.
    Eur Radiol. 2018 Dec 19. pii: 10.1007/s00330-018-5905.
    PubMed     Text format     Abstract available


  77. UHLIG J, Sellers CM, Stein SM, Kim HS, et al
    Radiofrequency ablation versus surgical resection of hepatocellular carcinoma: contemporary treatment trends and outcomes from the United States National Cancer Database.
    Eur Radiol. 2018 Dec 17. pii: 10.1007/s00330-018-5902.
    PubMed     Text format     Abstract available


  78. TANG A, Destrempes F, Kazemirad S, Garcia-Duitama J, et al
    Quantitative ultrasound and machine learning for assessment of steatohepatitis in a rat model.
    Eur Radiol. 2018 Dec 17. pii: 10.1007/s00330-018-5915.
    PubMed     Text format     Abstract available


  79. RHEE H, Kim MJ, Park YN, An C, et al
    A proposal of imaging classification of intrahepatic mass-forming cholangiocarcinoma into ductal and parenchymal types: clinicopathologic significance.
    Eur Radiol. 2018 Dec 17. pii: 10.1007/s00330-018-5898.
    PubMed     Text format     Abstract available


  80. PARK YS, Lee J, Kim JW, Park CM, et al
    Second shot arterial phase to overcome degraded hepatic arterial phase in liver MR imaging.
    Eur Radiol. 2018 Dec 14. pii: 10.1007/s00330-018-5897.
    PubMed     Text format     Abstract available


  81. LEE HS, Kim MJ, An C
    How to utilize LR-M features of the LI-RADS to improve the diagnosis of combined hepatocellular-cholangiocarcinoma on gadoxetate-enhanced MRI?
    Eur Radiol. 2018 Dec 14. pii: 10.1007/s00330-018-5893.
    PubMed     Text format     Abstract available


  82. FAZELI DEHKORDY S, Fowler KJ, Mamidipalli A, Wolfson T, et al
    Hepatic steatosis and reduction in steatosis following bariatric weight loss surgery differs between segments and lobes.
    Eur Radiol. 2018 Dec 13. pii: 10.1007/s00330-018-5894.
    PubMed     Text format     Abstract available


  83. KHOURI CHALOUHI C, Vernuccio F, Rini F, Duca P, et al
    Hepatobiliary phase in cirrhotic patients with different Model for End-stage Liver Disease score: comparison of the performance of gadoxetic acid to gadobenate dimeglumine.
    Eur Radiol. 2018 Dec 13. pii: 10.1007/s00330-018-5884.
    PubMed     Text format     Abstract available


  84. DONG Z, Huang K, Liao B, Cai H, et al
    Prediction of sorafenib treatment-related gene expression for hepatocellular carcinoma: preoperative MRI and histopathological correlation.
    Eur Radiol. 2018 Dec 13. pii: 10.1007/s00330-018-5882.
    PubMed     Text format     Abstract available


  85. NEIJENHUIS MK, Wijnands TFM, Kievit W, Ronot M, et al
    Symptom relief and not cyst reduction determines treatment success in aspiration sclerotherapy of hepatic cysts.
    Eur Radiol. 2018 Dec 12. pii: 10.1007/s00330-018-5851.
    PubMed     Text format     Abstract available


  86. BISE S, Frulio N, Hocquelet A, Alberti N, et al
    New MRI features improve subtype classification of hepatocellular adenoma.
    Eur Radiol. 2018 Dec 6. pii: 10.1007/s00330-018-5784.
    PubMed     Text format     Abstract available


  87. HAN A, Labyed Y, Sy EZ, Boehringer AS, et al
    Inter-sonographer reproducibility of quantitative ultrasound outcomes and shear wave speed measured in the right lobe of the liver in adults with known or suspected non-alcoholic fatty liver disease.
    Eur Radiol. 2018;28:4992-5000.
    PubMed     Text format     Abstract available


  88. BOULKHRIF H, Luu HM, van Walsum T, Moelker A, et al
    Accuracy of semi-automated versus manual localisation of liver tumours in CT-guided ablation procedures.
    Eur Radiol. 2018;28:4978-4984.
    PubMed     Text format     Abstract available


    November 2018
  89. CHA DI, Kang TW, Song KD, Lee MW, et al
    Radiofrequency ablation for subcardiac hepatocellular carcinoma: therapeutic outcomes and risk factors for technical failure.
    Eur Radiol. 2018 Nov 30. pii: 10.1007/s00330-018-5868.
    PubMed     Text format     Abstract available


  90. TSAUO J, Zhao H, Zhang X, Ma H, et al
    Changes in arterial oxygenation after portal decompression in Budd-Chiari syndrome patients with hepatopulmonary syndrome.
    Eur Radiol. 2018 Nov 30. pii: 10.1007/s00330-018-5840.
    PubMed     Text format     Abstract available


  91. HU HT, Wang Z, Huang XW, Chen SL, et al
    Ultrasound-based radiomics score: a potential biomarker for the prediction of microvascular invasion in hepatocellular carcinoma.
    Eur Radiol. 2018 Nov 12. pii: 10.1007/s00330-018-5797.
    PubMed     Text format     Abstract available


  92. WU M, Tan H, Gao F, Hai J, et al
    Predicting the grade of hepatocellular carcinoma based on non-contrast-enhanced MRI radiomics signature.
    Eur Radiol. 2018 Nov 7. pii: 10.1007/s00330-018-5787.
    PubMed     Text format     Abstract available


  93. BREGUET R, Boudabbous S, Pupulim LF, Becker CD, et al
    Ethylene vinyl alcohol copolymer for occlusion of specific portal branches during preoperative portal vein embolisation with n-butyl-cyanoacrylate.
    Eur Radiol. 2018;28:4810-4817.
    PubMed     Text format     Abstract available


    October 2018
  94. NAGAYAMA Y, Iyama A, Oda S, Taguchi N, et al
    Dual-layer dual-energy computed tomography for the assessment of hypovascular hepatic metastases: impact of closing k-edge on image quality and lesion detectability.
    Eur Radiol. 2018 Oct 30. pii: 10.1007/s00330-018-5789.
    PubMed     Text format     Abstract available


  95. YOUNG S, Craig P, Golzarian J
    Current trends in the treatment of hepatocellular carcinoma with transarterial embolization: a cross-sectional survey of techniques.
    Eur Radiol. 2018 Oct 22. pii: 10.1007/s00330-018-5782.
    PubMed     Text format     Abstract available


  96. MURTZ P, Sprinkart AM, Reick M, Pieper CC, et al
    Accurate IVIM model-based liver lesion characterisation can be achieved with only three b-value DWI.
    Eur Radiol. 2018;28:4418-4428.
    PubMed     Text format     Abstract available


  97. KIM C, Kim SY, Kim MJ, Yoon YS, et al
    Clinical impact of preoperative liver MRI in the evaluation of synchronous liver metastasis of colon cancer.
    Eur Radiol. 2018;28:4234-4242.
    PubMed     Text format     Abstract available


    September 2018
  98. MARQUARDT S, Kirstein MM, Bruning R, Zeile M, et al
    Percutaneous hepatic perfusion (chemosaturation) with melphalan in patients with intrahepatic cholangiocarcinoma: European multicentre study on safety, short-term effects and survival.
    Eur Radiol. 2018 Sep 25. pii: 10.1007/s00330-018-5729.
    PubMed     Text format     Abstract available


  99. IYAMA A, Nakaura T, Iyama Y, Kidoh M, et al
    Spiral flow-generating tube for saline chaser improves aortic enhancement in Gd-EOB-DTPA-enhanced hepatic MRI.
    Eur Radiol. 2018 Sep 25. pii: 10.1007/s00330-018-5733.
    PubMed     Text format     Abstract available


  100. JOO I, Lee JM, Lee DH, Jeon JH, et al
    Retrospective validation of a new diagnostic criterion for hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout with the aid of ancillary features?
    Eur Radiol. 2018 Sep 25. pii: 10.1007/s00330-018-5727.
    PubMed     Text format     Abstract available


  101. HAIMERL M, Fuhrmann I, Poelsterl S, Fellner C, et al
    Gd-EOB-DTPA-enhanced T1 relaxometry for assessment of liver function determined by real-time (13)C-methacetin breath test.
    Eur Radiol. 2018;28:3591-3600.
    PubMed     Text format     Abstract available


    August 2018
  102. BRENET DEFOUR L, Mule S, Tenenhaus A, Piardi T, et al
    Hepatocellular carcinoma: CT texture analysis as a predictor of survival after surgical resection.
    Eur Radiol. 2018 Aug 29. pii: 10.1007/s00330-018-5679.
    PubMed     Text format     Abstract available


  103. NGUYEN L, Cazzagon N, Corpechot C, El Mouhadi S, et al
    Intrahepatic cystic biliary dilatation constitutes a significant prognostic factor in patients with primary sclerosing cholangitis.
    Eur Radiol. 2018 Aug 29. pii: 10.1007/s00330-018-5697.
    PubMed     Text format     Abstract available


  104. LEE DH, Lee JM, Chang W, Yoon JH, et al
    Prognostic Role of Liver Stiffness Measurements Using Magnetic Resonance Elastography in Patients with Compensated Chronic Liver Disease.
    Eur Radiol. 2018;28:3513-3521.
    PubMed     Text format     Abstract available


  105. CHEUNG HMC, Karanicolas PJ, Hsieh E, Coburn N, et al
    Late gadolinium enhancement of colorectal liver metastases post-chemotherapy is associated with tumour fibrosis and overall survival post-hepatectomy.
    Eur Radiol. 2018;28:3505-3512.
    PubMed     Text format     Abstract available


  106. LIN H, Wei H, He N, Fu C, et al
    Quantitative susceptibility mapping in combination with water-fat separation for simultaneous liver iron and fat fraction quantification.
    Eur Radiol. 2018;28:3494-3504.
    PubMed     Text format     Abstract available


  107. JEON SK, Lee JM, Joo I, Lee DH, et al
    Magnetic resonance with diffusion-weighted imaging improves assessment of focal liver lesions in patients with potentially resectable pancreatic cancer on CT.
    Eur Radiol. 2018;28:3484-3493.
    PubMed     Text format     Abstract available


    July 2018
  108. HUI SCN, Wong SKH, Ai Q, Yeung DKW, et al
    Observed changes in brown, white, hepatic and pancreatic fat after bariatric surgery: Evaluation with MRI.
    Eur Radiol. 2018 Jul 30. pii: 10.1007/s00330-018-5611.
    PubMed     Text format     Abstract available


  109. ICHIKAWA S, Motosugi U, Enomoto N, Onishi H, et al
    Magnetic resonance elastography can predict development of hepatocellular carcinoma with longitudinally acquired two-point data.
    Eur Radiol. 2018 Jul 24. pii: 10.1007/s00330-018-5640.
    PubMed     Text format     Abstract available


  110. KIM R, Kang TW, Cha DI, Song KD, et al
    Percutaneous cryoablation for perivascular hepatocellular carcinoma: Therapeutic efficacy and vascular complications.
    Eur Radiol. 2018 Jul 24. pii: 10.1007/s00330-018-5617.
    PubMed     Text format     Abstract available


  111. YU J, Wang X, Jiang M, Ma H, et al
    Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone and combined with embolisation for the management of cardiofundal varices: a retrospective study.
    Eur Radiol. 2018 Jul 23. pii: 10.1007/s00330-018-5645.
    PubMed     Text format     Abstract available


  112. WEI Y, Gao F, Wang M, Huang Z, et al
    Intravoxel incoherent motion diffusion-weighted imaging for assessment of histologic grade of hepatocellular carcinoma: comparison of three methods for positioning region of interest.
    Eur Radiol. 2018 Jul 19. pii: 10.1007/s00330-018-5638.
    PubMed     Text format     Abstract available


  113. PLAIKNER M, Kremser C, Zoller H, Steurer M, et al
    Does gadoxetate disodium affect MRE measurements in the delayed hepatobiliary phase?
    Eur Radiol. 2018 Jul 19. pii: 10.1007/s00330-018-5616.
    PubMed     Text format     Abstract available


  114. KELLER S, Sedlacik J, Schuler T, Buchert R, et al
    Prospective comparison of diffusion-weighted MRI and dynamic Gd-EOB-DTPA-enhanced MRI for detection and staging of hepatic fibrosis in primary sclerosing cholangitis.
    Eur Radiol. 2018 Jul 16. pii: 10.1007/s00330-018-5614.
    PubMed     Text format     Abstract available


  115. SEO N, Kim MS, Park MS, Choi JY, et al
    Optimal criteria for hepatocellular carcinoma diagnosis using CT in patients undergoing liver transplantation.
    Eur Radiol. 2018 Jul 4. pii: 10.1007/s00330-018-5557.
    PubMed     Text format     Abstract available


  116. CALANDRI M, Yamashita S, Gazzera C, Fonio P, et al
    Ablation of colorectal liver metastasis: Interaction of ablation margins and RAS mutation profiling on local tumour progression-free survival.
    Eur Radiol. 2018;28:2727-2734.
    PubMed     Text format     Abstract available


  117. SEO N, Chung YE, Park YN, Kim E, et al
    Liver fibrosis: stretched exponential model outperforms mono-exponential and bi-exponential models of diffusion-weighted MRI.
    Eur Radiol. 2018;28:2812-2822.
    PubMed     Text format     Abstract available


  118. YANG L, Rao S, Wang W, Chen C, et al
    Staging liver fibrosis with DWI: is there an added value for diffusion kurtosis imaging?
    Eur Radiol. 2018;28:3041-3049.
    PubMed     Text format     Abstract available


  119. AMADORI M, Barone D, Scarpi E, Oboldi D, et al
    Dynamic contrast-enhanced ultrasonography (D-CEUS) for the early prediction of bevacizumab efficacy in patients with metastatic colorectal cancer.
    Eur Radiol. 2018;28:2969-2978.
    PubMed     Text format     Abstract available


    June 2018
  120. JEON SK, Joo I, Lee DH, Lee SM, et al
    Combined hepatocellular cholangiocarcinoma: LI-RADS v2017 categorisation for differential diagnosis and prognostication on gadoxetic acid-enhanced MR imaging.
    Eur Radiol. 2018 Jun 28. pii: 10.1007/s00330-018-5605.
    PubMed     Text format     Abstract available


  121. WU LF, Rao SX, Xu PJ, Yang L, et al
    Pre-TACE kurtosis of ADCtotal derived from histogram analysis for diffusion-weighted imaging is the best independent predictor of prognosis in hepatocellular carcinoma.
    Eur Radiol. 2018 Jun 19. pii: 10.1007/s00330-018-5482.
    PubMed     Text format     Abstract available


  122. SONG JS, Choi EJ, Hwang SB, Hwang HP, et al
    LI-RADS v2014 categorization of hepatocellular carcinoma: Intraindividual comparison between gadopentetate dimeglumine-enhanced MRI and gadoxetic acid-enhanced MRI.
    Eur Radiol. 2018 Jun 19. pii: 10.1007/s00330-018-5559.
    PubMed     Text format     Abstract available


  123. REFAAT R, Basha MAA, Hassan MS, Hussein RS, et al
    Efficacy of contrast-enhanced FDG PET/CT in patients awaiting liver transplantation with rising alpha-fetoprotein after bridge therapy of hepatocellular carcinoma.
    Eur Radiol. 2018 Jun 12. pii: 10.1007/s00330-018-5425.
    PubMed     Text format     Abstract available


  124. SONG J, Ma Z, Huang J, Liu S, et al
    Comparison of three cut-offs to diagnose clinically significant portal hypertension by liver stiffness in chronic viral liver diseases: a meta-analysis.
    Eur Radiol. 2018 Jun 1. pii: 10.1007/s00330-018-5478.
    PubMed     Text format     Abstract available


  125. DE ROBERTIS R, Maris B, Cardobi N, Tinazzi Martini P, et al
    Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors?
    Eur Radiol. 2018;28:2582-2591.
    PubMed     Text format     Abstract available


    May 2018
  126. ASENBAUM U, Kaczirek K, Ba-Ssalamah A, Ringl H, et al
    Post-hepatectomy liver failure after major hepatic surgery: not only size matters.
    Eur Radiol. 2018 May 16. pii: 10.1007/s00330-018-5487.
    PubMed     Text format     Abstract available


  127. WINTER KS, Hofmann FO, Thierfelder KM, Holch JW, et al
    Towards volumetric thresholds in RECIST 1.1: Therapeutic response assessment in hepatic metastases.
    Eur Radiol. 2018 May 7. pii: 10.1007/s00330-018-5424.
    PubMed     Text format     Abstract available


  128. SIVESGAARD K, Larsen LP, Sorensen M, Kramer S, et al
    Diagnostic accuracy of CE-CT, MRI and FDG PET/CT for detecting colorectal cancer liver metastases in patients considered eligible for hepatic resection and/or local ablation.
    Eur Radiol. 2018 May 7. pii: 10.1007/s00330-018-5469.
    PubMed     Text format     Abstract available


  129. REIZINE E, Amaddeo G, Pigneur F, Baranes L, et al
    Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions.
    Eur Radiol. 2018 May 2. pii: 10.1007/s00330-018-5438.
    PubMed     Text format     Abstract available


  130. TANAKA T, Masada T, Nishiofuku H, Fukuoka Y, et al
    Development of pumping emulsification device with glass membrane to form ideal lipiodol emulsion in transarterial chemoembolization.
    Eur Radiol. 2018;28:2203-2207.
    PubMed     Text format     Abstract available


  131. GRUBER L, Rainer V, Plaikner M, Kremser C, et al
    CAIPIRINHA-Dixon-TWIST (CDT)-VIBE MR imaging of the liver at 3.0T with gadoxetate disodium: a solution for transient arterial-phase respiratory motion-related artifacts?
    Eur Radiol. 2018;28:2013-2021.
    PubMed     Text format     Abstract available


  132. XU L, Duanmu Y, Blake GM, Zhang C, et al
    Validation of goose liver fat measurement by QCT and CSE-MRI with biochemical extraction and pathology as reference.
    Eur Radiol. 2018;28:2003-2012.
    PubMed     Text format     Abstract available


  133. KIM YY, An C, Kim S, Kim MJ, et al
    Diagnostic accuracy of prospective application of the Liver Imaging Reporting and Data System (LI-RADS) in gadoxetate-enhanced MRI.
    Eur Radiol. 2018;28:2038-2046.
    PubMed     Text format     Abstract available


  134. WU M, Li L, Wang J, Zhang Y, et al
    Contrast-enhanced US for characterization of focal liver lesions: a comprehensive meta-analysis.
    Eur Radiol. 2018;28:2077-2088.
    PubMed     Text format     Abstract available


    April 2018
  135. GETZIN T, Gueler F, Hartleben B, Gutberlet M, et al
    Gd-EOB-DTPA-enhanced MRI for quantitative assessment of liver organ damage after partial hepatic ischaemia reperfusion injury: correlation with histology and serum biomarkers of liver cell injury.
    Eur Radiol. 2018 Apr 30. pii: 10.1007/s00330-018-5380.
    PubMed     Text format     Abstract available


  136. ZHANG HX, Fu JF, Lai C, Tian FY, et al
    Feasibility of balanced steady-state free precession sequence at 1.5T for the evaluation of hepatic steatosis in obese children and adolescents.
    Eur Radiol. 2018 Apr 30. pii: 10.1007/s00330-018-5344.
    PubMed     Text format     Abstract available


  137. SCHELLHAAS B, Hammon M, Strobel D, Pfeifer L, et al
    Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS.
    Eur Radiol. 2018 Apr 19. pii: 10.1007/s00330-018-5379.
    PubMed     Text format     Abstract available


  138. AKAI H, Yasaka K, Kunimatsu A, Nojima M, et al
    The inhibitory effect of gadoxetate disodium on hepatic transporters: a study using indocyanine green.
    Eur Radiol. 2018 Apr 12. pii: 10.1007/s00330-018-5403.
    PubMed     Text format     Abstract available


  139. SANDRASEGARAN K, Cui E, Elkady R, Gasparis P, et al
    Can functional parameters from hepatobiliary phase of gadoxetate MRI predict clinical outcomes in patients with cirrhosis?
    Eur Radiol. 2018 Apr 12. pii: 10.1007/s00330-018-5366.
    PubMed     Text format     Abstract available


  140. TOVOLI F, Renzulli M, Negrini G, Brocchi S, et al
    Inter-operator variability and source of errors in tumour response assessment for hepatocellular carcinoma treated with sorafenib.
    Eur Radiol. 2018 Apr 9. pii: 10.1007/s00330-018-5393.
    PubMed     Text format     Abstract available


  141. KIM YS, Jang YN, Song JS
    Comparison of gradient-recalled echo and spin-echo echo-planar imaging MR elastography in staging liver fibrosis: a meta-analysis.
    Eur Radiol. 2018;28:1709-1718.
    PubMed     Text format     Abstract available


  142. LEE SJ, Zea R, Kim DH, Lubner MG, et al
    CT texture features of liver parenchyma for predicting development of metastatic disease and overall survival in patients with colorectal cancer.
    Eur Radiol. 2018;28:1520-1528.
    PubMed     Text format     Abstract available


  143. PEREIRA PL, Kruger K, Hohenstein E, Welke F, et al
    Intraprocedural 3D perfusion measurement during chemoembolisation with doxorubicin-eluting beads in liver metastases of malignant melanoma.
    Eur Radiol. 2018;28:1456-1464.
    PubMed     Text format     Abstract available


  144. SEMELKA RC, Nimojan N, Chandana S, Ramalho M, et al
    MRI features of primary rare malignancies of the liver: A report from four university centres.
    Eur Radiol. 2018;28:1529-1539.
    PubMed     Text format     Abstract available


  145. HWANG SM, Jeon TY, Yoo SY, Choe YH, et al
    Early US findings of biliary atresia in infants younger than 30 days.
    Eur Radiol. 2018;28:1771-1777.
    PubMed     Text format     Abstract available


  146. BROUHA SS, Nguyen P, Bettencourt R, Sirlin CB, et al
    Increased severity of liver fat content and liver fibrosis in non-alcoholic fatty liver disease correlate with epicardial fat volume in type 2 diabetes: A prospective study.
    Eur Radiol. 2018;28:1345-1355.
    PubMed     Text format     Abstract available


    March 2018
  147. LUO J, Li M, Zhang Y, Wang H, et al
    Percutaneous transhepatic intrahepatic portosystemic shunt for variceal bleeding with chronic portal vein occlusion after splenectomy.
    Eur Radiol. 2018 Mar 29. pii: 10.1007/s00330-018-5360.
    PubMed     Text format     Abstract available


  148. CHEN S, Peng Z, Lin M, Chen Z, et al
    Combined percutaneous radiofrequency ablation and ethanol injection versus hepatic resection for 2.1-5.0 cm solitary hepatocellular carcinoma: a retrospective comparative multicentre study.
    Eur Radiol. 2018 Mar 29. pii: 10.1007/s00330-018-5371.
    PubMed     Text format     Abstract available


  149. HEERINK WJ, Solouki AM, Vliegenthart R, Ruiter SJS, et al
    The relationship between applied energy and ablation zone volume in patients with hepatocellular carcinoma and colorectal liver metastasis.
    Eur Radiol. 2018 Mar 13. pii: 10.1007/s00330-017-5266.
    PubMed     Text format     Abstract available


  150. PENG Z, Wei M, Chen S, Lin M, et al
    Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.
    Eur Radiol. 2018 Mar 13. pii: 10.1007/s00330-017-5166.
    PubMed     Text format     Abstract available


  151. SONG JS, Choi EJ, Park EH, Lee JH, et al
    Comparison of transient severe motion in gadoxetate disodium and gadopentetate dimeglumine-enhanced MRI: effect of modified breath-holding method.
    Eur Radiol. 2018;28:1132-1139.
    PubMed     Text format     Abstract available


  152. BRAAT AJAT, Prince JF, van Rooij R, Bruijnen RCG, et al
    Safety analysis of holmium-166 microsphere scout dose imaging during radioembolisation work-up: A cohort study.
    Eur Radiol. 2018;28:920-928.
    PubMed     Text format     Abstract available


  153. KIM JR, Suh CH, Yoon HM, Lee JS, et al
    The diagnostic performance of shear-wave elastography for liver fibrosis in children and adolescents: A systematic review and diagnostic meta-analysis.
    Eur Radiol. 2018;28:1175-1186.
    PubMed     Text format     Abstract available


    February 2018
  154. DE CECCO CN, Caruso D, Schoepf UJ, De Santis D, et al
    A noise-optimized virtual monoenergetic reconstruction algorithm improves the diagnostic accuracy of late hepatic arterial phase dual-energy CT for the detection of hypervascular liver lesions.
    Eur Radiol. 2018 Feb 19. pii: 10.1007/s00330-018-5313.
    PubMed     Text format     Abstract available


  155. LUO X, Wang X, Yu J, Zhu Y, et al
    Transjugular intrahepatic portosystemic shunt creation: three-dimensional roadmap versus CO2 wedged hepatic venography.
    Eur Radiol. 2018 Feb 19. pii: 10.1007/s00330-018-5316.
    PubMed     Text format     Abstract available


  156. NAGANAWA S, Enooku K, Tateishi R, Akai H, et al
    Imaging prediction of nonalcoholic steatohepatitis using computed tomography texture analysis.
    Eur Radiol. 2018 Feb 5. pii: 10.1007/s00330-017-5270.
    PubMed     Text format     Abstract available


  157. AKAI H, Yasaka K, Nojima M, Kunimatsu A, et al
    Gadoxetate disodium-induced tachypnoea and the effect of dilution method: a proof-of-concept study in mice.
    Eur Radiol. 2018;28:692-697.
    PubMed     Text format     Abstract available


    January 2018
  158. NAJMI VARZANEH F, Pandey A, Aliyari Ghasabeh M, Shao N, et al
    Prediction of post-TACE necrosis of hepatocellular carcinoma usingvolumetric enhancement on MRI and volumetric oil deposition on CT, with pathological correlation.
    Eur Radiol. 2018 Jan 30. pii: 10.1007/s00330-017-5198.
    PubMed     Text format     Abstract available


  159. CIOLINA M, Di Martino M, Bruno O, Pommier R, et al
    Peritoneal and pleural fluids may appear hyperintense on hepatobiliary phase using hepatobiliary MR contrast agents.
    Eur Radiol. 2018 Jan 26. pii: 10.1007/s00330-017-5261.
    PubMed     Text format     Abstract available


  160. BASHA MAA, AlAzzazy MZ, Ahmed AF, Yousef HY, et al
    Does a combined CT and MRI protocol enhance the diagnostic efficacy of LI-RADS in the categorization of hepatic observations? A prospective comparative study.
    Eur Radiol. 2018 Jan 24. pii: 10.1007/s00330-017-5232.
    PubMed     Text format     Abstract available


  161. MIN JH, Kang TW, Kim YK, Kim SH, et al
    Hepatic neuroendocrine tumour: Apparent diffusion coefficient as a potential marker of prognosis associated with tumour grade and overall survival.
    Eur Radiol. 2018 Jan 24. pii: 10.1007/s00330-017-5248.
    PubMed     Text format     Abstract available


  162. CHOI SY, Kim YK, Min JH, Kang TW, et al
    Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging.
    Eur Radiol. 2018 Jan 15. pii: 10.1007/s00330-017-5196.
    PubMed     Text format     Abstract available


  163. WIJNANDS TFM, Gevers TJG, Lantinga MA, Te Morsche RH, et al
    Pasireotide does not improve efficacy of aspiration sclerotherapy in patients with large hepatic cysts, a randomized controlled trial.
    Eur Radiol. 2018 Jan 9. pii: 10.1007/s00330-017-5205.
    PubMed     Text format     Abstract available


  164. PARK JE, Choi YH, Cheon JE, Kim WS, et al
    Gallbladder wall oedema and ascites are independent predictors of progression to hepatic veno-occlusive disease for children with hematopoietic stem cell transplantation.
    Eur Radiol. 2018 Jan 2. pii: 10.1007/s00330-017-5137.
    PubMed     Text format     Abstract available


    December 2017
  165. LEWIS S, Besa C, Wagner M, Jhaveri K, et al
    Prediction of the histopathologic findings of intrahepatic cholangiocarcinoma: qualitative and quantitative assessment of diffusion-weighted imaging.
    Eur Radiol. 2017 Dec 12. pii: 10.1007/s00330-017-5156.
    PubMed     Text format     Abstract available


  166. PARK SH, Lee SS, Sung JY, Na K, et al
    Noninvasive assessment of hepatic sinusoidal obstructive syndrome using acoustic radiation force impulse elastography imaging: A proof-of-concept study in rat models.
    Eur Radiol. 2017 Dec 7. pii: 10.1007/s00330-017-5179.
    PubMed     Text format     Abstract available


  167. CHOI JW, Chung JW, Lee DH, Kim HC, et al
    Portal hypertension is associated with poor outcome of transarterial chemoembolization in patients with hepatocellular carcinoma.
    Eur Radiol. 2017 Dec 7. pii: 10.1007/s00330-017-5145.
    PubMed     Text format     Abstract available


  168. MINAMI Y, Minami T, Hagiwara S, Ida H, et al
    Ultrasound-ultrasound image overlay fusion improves real-time control of radiofrequency ablation margin in the treatment of hepatocellular carcinoma.
    Eur Radiol. 2017 Dec 1. pii: 10.1007/s00330-017-5162.
    PubMed     Text format     Abstract available


    November 2017
  169. MULE S, Pigneur F, Quelever R, Tenenhaus A, et al
    Can dual-energy CT replace perfusion CT for the functional evaluation of advanced hepatocellular carcinoma?
    Eur Radiol. 2017 Nov 22. doi: 10.1007/s00330-017-5151.
    PubMed     Text format     Abstract available


  170. LEE SE, An C, Hwang SH, Choi JY, et al
    Extracellular contrast agent-enhanced MRI: 15-min delayed phase may improve the diagnostic performance for hepatocellular carcinoma in patients with chronic liver disease.
    Eur Radiol. 2017 Nov 13. doi: 10.1007/s00330-017-5119.
    PubMed     Text format     Abstract available


  171. PARK J, Kim HC, Lee JH, Cho E, et al
    Chemoembolisation for hepatocellular carcinoma with bile duct invasion: is preprocedural biliary drainage mandatory?
    Eur Radiol. 2017 Nov 9. doi: 10.1007/s00330-017-5110.
    PubMed     Text format     Abstract available


    October 2017
  172. NAGAYAMA Y, Nakaura T, Oda S, Utsunomiya D, et al
    Dual-layer DECT for multiphasic hepatic CT with 50 percent iodine load: a matched-pair comparison with a 120 kVp protocol.
    Eur Radiol. 2017 Oct 23. doi: 10.1007/s00330-017-5114.
    PubMed     Text format     Abstract available


  173. PARK CJ, An C, Park S, Choi JY, et al
    Management of subcentimetre arterially enhancing and hepatobiliary hypointense lesions on gadoxetic acid-enhanced MRI in patients at risk for HCC.
    Eur Radiol. 2017 Oct 23. doi: 10.1007/s00330-017-5088.
    PubMed     Text format     Abstract available


    September 2017
  174. RENZULLI M, Buonfiglioli F, Conti F, Brocchi S, et al
    Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis.
    Eur Radiol. 2017 Sep 11. doi: 10.1007/s00330-017-5033.
    PubMed     Text format     Abstract available


  175. FANG J, Ma X, Yu D, Ma X, et al
    Specific imaging characteristic of solitary necrotic nodule of the liver: Marked peripheral rim-like enhancement with internal hypointensity on longer delayed MRI.
    Eur Radiol. 2017;27:3563-3573.
    PubMed     Text format     Abstract available


    August 2017
  176. HU H, Han H, Han XK, Wang WP, et al
    Nomogram for individualised prediction of liver failure risk after hepatectomy in patients with resectable hepatocellular carcinoma: the evidence from ultrasound data.
    Eur Radiol. 2017 Aug 4. doi: 10.1007/s00330-017-4900.
    PubMed     Text format     Abstract available


  177. GUIU B, Quenet F, Escal L, Bibeau F, et al
    Extended liver venous deprivation before major hepatectomy induces marked and very rapid increase in future liver remnant function.
    Eur Radiol. 2017;27:3343-3352.
    PubMed     Text format     Abstract available


  178. CHUNG MS, Kim HS, Lim YS, Jeon SB, et al
    Clinical impact of preoperative brain MR angiography and MR imaging in candidates for liver transplantation: a propensity score-matching study in a single institution.
    Eur Radiol. 2017;27:3532-3541.
    PubMed     Text format     Abstract available


  179. SOMERS I, Bipat S
    Contrast-enhanced CT in determining resectability in patients with pancreatic carcinoma: a meta-analysis of the positive predictive values of CT.
    Eur Radiol. 2017;27:3408-3435.
    PubMed     Text format     Abstract available


  180. ZHOU LY, Jiang H, Shan QY, Chen D, et al
    Liver stiffness measurements with supersonic shear wave elastography in the diagnosis of biliary atresia: a comparative study with grey-scale US.
    Eur Radiol. 2017;27:3474-3484.
    PubMed     Text format     Abstract available


    July 2017
  181. ZHU Y, Chen J, Kong W, Mao L, et al
    Predicting IDH mutation status of intrahepatic cholangiocarcinomas based on contrast-enhanced CT features.
    Eur Radiol. 2017 Jul 27. doi: 10.1007/s00330-017-4957.
    PubMed     Text format     Abstract available


  182. LEE S, Kim JH, Lee JH, Lee JH, et al
    Non-invasive monitoring of the therapeutic response in sorafenib-treated hepatocellular carcinoma based on photoacoustic imaging.
    Eur Radiol. 2017 Jul 27. doi: 10.1007/s00330-017-4960.
    PubMed     Text format     Abstract available


  183. SUH CH, Kim KW, Park SH, Shin S, et al
    A cost-effectiveness analysis of the diagnostic strategies for differentiating focal nodular hyperplasia from hepatocellular adenoma.
    Eur Radiol. 2017 Jul 19. doi: 10.1007/s00330-017-4967.
    PubMed     Text format     Abstract available


  184. HAMIE QM, Kobe AR, Mietzsch L, Manhart M, et al
    Prototype metal artefact reduction algorithm in flat panel computed tomography - evaluation in patients undergoing transarterial hepatic radioembolisation.
    Eur Radiol. 2017 Jul 14. doi: 10.1007/s00330-017-4946.
    PubMed     Text format     Abstract available


  185. GEISEL D, Raabe P, Ludemann L, Malinowski M, et al
    Gd-EOB-DTPA-enhanced MRI for monitoring future liver remnant function after portal vein embolization and extended hemihepatectomy: A prospective trial.
    Eur Radiol. 2017;27:3080-3087.
    PubMed     Text format     Abstract available


  186. NAKAMOTO A, Tanaka Y, Juri H, Nakai G, et al
    Diagnostic performance of reduced-dose CT with a hybrid iterative reconstruction algorithm for the detection of hypervascular liver lesions: a phantom study.
    Eur Radiol. 2017;27:2995-3003.
    PubMed     Text format     Abstract available


  187. KIM SS, Song KD, Kim YK, Kim HC, et al
    Disappearing or residual tiny (</=5 mm) colorectal liver metastases after chemotherapy on gadoxetic acid-enhanced liver MRI and diffusion-weighted imaging: Is local treatment required?
    Eur Radiol. 2017;27:3088-3096.
    PubMed     Text format     Abstract available


    June 2017
  188. CHEN HJ, Shi HB, Jiang LF, Li L, et al
    Disrupted topological organization of brain structural network associated with prior overt hepatic encephalopathy in cirrhotic patients.
    Eur Radiol. 2017 Jun 30. doi: 10.1007/s00330-017-4887.
    PubMed     Text format     Abstract available


  189. FRYDRYCHOWICZ A, Roldan-Alzate A, Winslow E, Consigny D, et al
    Comparison of radial 4D Flow-MRI with perivascular ultrasound to quantify blood flow in the abdomen and introduction of a porcine model of pre-hepatic portal hypertension.
    Eur Radiol. 2017 Jun 27. doi: 10.1007/s00330-017-4862.
    PubMed     Text format     Abstract available


  190. JUNG C, Groth M, Petersen KU, Hammel A, et al
    Hepatic shear wave elastography in children under free-breathing and breath-hold conditions.
    Eur Radiol. 2017 Jun 20. doi: 10.1007/s00330-017-4909.
    PubMed     Text format     Abstract available


  191. LEE BC, Liu KL, Lin CL, Kao CH, et al
    Risk of acute kidney injury after transarterial chemoembolisation in hepatocellular carcinoma patients: A nationwide population-based cohort study.
    Eur Radiol. 2017 Jun 7. doi: 10.1007/s00330-017-4893.
    PubMed     Text format     Abstract available


  192. DIPAOLA FW, Schumacher KR, Goldberg CS, Friedland-Little J, et al
    Effect of Fontan operation on liver stiffness in children with single ventricle physiology.
    Eur Radiol. 2017;27:2434-2442.
    PubMed     Text format     Abstract available


    May 2017
  193. ZHENG G, Lu H, Yu W, Luo S, et al
    Severity-specific alterations in CBF, OEF and CMRO2 in cirrhotic patients with hepatic encephalopathy.
    Eur Radiol. 2017 May 18. doi: 10.1007/s00330-017-4809.
    PubMed     Text format     Abstract available


  194. HWANG J, Kim YK, Min JH, Choi SY, et al
    Capsule, septum, and T2 hyperintense foci for differentiation between large hepatocellular carcinoma (>/=5 cm) and intrahepatic cholangiocarcinoma on gadoxetic acid MRI.
    Eur Radiol. 2017 May 12. doi: 10.1007/s00330-017-4846.
    PubMed     Text format     Abstract available


  195. POOLER BD, Lubner MG, Kim DH, Chen OT, et al
    Prospective Evaluation of Reduced Dose Computed Tomography for the Detection of Low-Contrast Liver Lesions: Direct Comparison with Concurrent Standard Dose Imaging.
    Eur Radiol. 2017;27:2055-2066.
    PubMed     Text format     Abstract available


  196. YU J, Xu Q, Huang DY, Song JC, et al
    Prognostic aspects of dynamic contrast-enhanced magnetic resonance imaging in synchronous distant metastatic rectal cancer.
    Eur Radiol. 2017;27:1840-1847.
    PubMed     Text format     Abstract available


  197. KOOB M, Pariente D, Habes D, Ducot B, et al
    The porta hepatis microcyst: an additional sonographic sign for the diagnosis of biliary atresia.
    Eur Radiol. 2017;27:1812-1821.
    PubMed     Text format     Abstract available


    April 2017
  198. TAOULI B, Hoshida Y, Kakite S, Chen X, et al
    Imaging-based surrogate markers of transcriptome subclasses and signatures in hepatocellular carcinoma: preliminary results.
    Eur Radiol. 2017 Apr 24. doi: 10.1007/s00330-017-4844.
    PubMed     Text format     Abstract available


  199. WOO JH, Song KD, Kim SH
    Subcentimeter hypervascular nodules with typical imaging findings of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: Outcomes of early treatment and watchful waiting.
    Eur Radiol. 2017 Apr 6. doi: 10.1007/s00330-017-4818.
    PubMed     Text format     Abstract available


  200. HERATH NI, Devun F, Herbette A, Lienafa MC, et al
    Potentiation of doxorubicin efficacy in hepatocellular carcinoma by the DNA repair inhibitor DT01 in preclinical models.
    Eur Radiol. 2017 Apr 3. doi: 10.1007/s00330-017-4792.
    PubMed     Text format     Abstract available


    March 2017
  201. CHOI SY, Kim YK, Min JH, Cha DI, et al
    The value of gadoxetic acid-enhanced MRI for differentiation between hepatic microabscesses and metastases in patients with periampullary cancer.
    Eur Radiol. 2017 Mar 24. doi: 10.1007/s00330-017-4782.
    PubMed     Text format     Abstract available


  202. TALAKIC E, Schaffellner S, Kniepeiss D, Mueller H, et al
    CT perfusion imaging of the liver and the spleen in patients with cirrhosis: Is there a correlation between perfusion and portal venous hypertension?
    Eur Radiol. 2017 Mar 20. doi: 10.1007/s00330-017-4788.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: